These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20634301)

  • 1. BTBR Ob/Ob mutant mice model progressive diabetic nephropathy.
    Hudkins KL; Pichaiwong W; Wietecha T; Kowalewska J; Banas MC; Spencer MW; Mühlfeld A; Koelling M; Pippin JW; Shankland SJ; Askari B; Rabaglia ME; Keller MP; Attie AD; Alpers CE
    J Am Soc Nephrol; 2010 Sep; 21(9):1533-42. PubMed ID: 20634301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy.
    Hudkins KL; Wietecha TA; Steegh F; Alpers CE
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1295-F1305. PubMed ID: 32249614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse.
    Askari B; Wietecha T; Hudkins KL; Fox EJ; O'Brien KD; Kim J; Nguyen TQ; Alpers CE
    Lab Invest; 2014 Aug; 94(8):851-62. PubMed ID: 24955894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of diabetic nephropathy.
    Alpers CE; Hudkins KL
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):278-84. PubMed ID: 21422926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
    Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F317-25. PubMed ID: 24944269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term expression of glomerular genes in diabetic nephropathy.
    Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
    Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice.
    Albrecht T; Schilperoort M; Zhang S; Braun JD; Qiu J; Rodriguez A; Pastene DO; Krämer BK; Köppel H; Baelde H; de Heer E; Anna Altomare A; Regazzoni L; Denisi A; Aldini G; van den Born J; Yard BA; Hauske SJ
    Sci Rep; 2017 Mar; 7():44492. PubMed ID: 28281693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new model of diabetic nephropathy in C57BL/6 mice challenged with advanced oxidation protein products.
    Bai X; Li X; Tian J; Xu L; Wan J; Liu Y
    Free Radic Biol Med; 2018 Apr; 118():71-84. PubMed ID: 29462715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of diabetic nephropathy by treatment with empagliflozin in BTBR ob/ob mice.
    Hudkins KL; Li X; Holland AL; Swaminathan S; Alpers CE
    Nephrol Dial Transplant; 2022 Apr; 37(5):847-859. PubMed ID: 34865099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy.
    Pichaiwong W; Hudkins KL; Wietecha T; Nguyen TQ; Tachaudomdach C; Li W; Askari B; Kobayashi T; O'Brien KD; Pippin JW; Shankland SJ; Alpers CE
    J Am Soc Nephrol; 2013 Jun; 24(7):1088-102. PubMed ID: 23641056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Analysis of Obesity-Induced Diabetic Nephropathy in BTBR Mice.
    Keller MP; O'Connor C; Bitzer M; Schueler KL; Stapleton DS; Emfinger CH; Broman AT; Hodgin JB; Attie AD
    Diabetes; 2024 Feb; 73(2):312-317. PubMed ID: 37935024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy.
    Lavoz C; Matus YS; Orejudo M; Carpio JD; Droguett A; Egido J; Mezzano S; Ruiz-Ortega M
    Kidney Int; 2019 Jun; 95(6):1418-1432. PubMed ID: 30982673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grem2 mediates podocyte apoptosis in high glucose milieu.
    Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC
    Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses.
    O'Brien PD; Hur J; Hayes JM; Backus C; Sakowski SA; Feldman EL
    Neurobiol Dis; 2015 Jan; 73():348-55. PubMed ID: 25447227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
    Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
    J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosinase-1 overexpression, but not aerobic exercise training, affects the development of diabetic nephropathy in BTBR
    Everaert I; He J; Hanssens M; Stautemas J; Bakker K; Albrecht T; Zhang S; Van der Stede T; Vanhove K; Hoetker D; Howsam M; Tessier FJ; Yard B; Baba SP; Baelde HJ; Derave W
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1030-F1040. PubMed ID: 32150446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy.
    Attie AD; Schueler KM; Keller MP; Mitok KA; Simonett SP; Hudkins KL; Mehrotra K; Graham MJ; Lee RG; Alpers CE
    Lab Invest; 2021 Jul; 101(7):935-941. PubMed ID: 33911188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A diet containing cod backbone proteins attenuated the development of mesangial sclerosis and tubular dysfunction in male obese BTBR ob/ob mice.
    O'Keeffe M; Oterhals Å; Weishaupt H; Leh S; Ulvik A; Ueland PM; Halstensen A; Marti HP; Gudbrandsen OA
    Eur J Nutr; 2023 Dec; 62(8):3227-3240. PubMed ID: 37550593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.